| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.99▲ | 3.01▼ | 3.01▼ | 3.19▼ | 3.61▼ |
| MA10 | 3.03▼ | 3.06▼ | 3.07▼ | 3.36▼ | 3.62▼ |
| MA20 | 3.10▼ | 3.14▼ | 3.17▼ | 3.63▼ | 3.85▼ |
| MA50 | 3.28▼ | 3.35▼ | 3.42▼ | 3.68▼ | 5.06▼ |
| MA100 | 3.46▼ | 3.58▼ | 3.66▼ | 3.91▼ | 6.67▼ |
| MA200 | 3.70▼ | 3.69▼ | 3.68▼ | 4.88▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.007▼ | -0.006▼ | -0.075▼ | 0.005▲ |
| RSI | 34.551▼ | 31.778▼ | 28.053▼ | 26.562▼ | 33.135▼ |
| STOCH | 9.367▼ | 11.107▼ | 9.642▼ | 7.442▼ | 27.641 |
| WILL %R | -76.471▼ | -85.714▼ | -85.714▼ | -96.364▼ | -97.202▼ |
| CCI | -58.722 | -81.749 | -81.843 | -149.977▼ | -199.269▼ |
|
Monday, November 15, 2021 04:38 AM
Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing transformative, targeted therapeutics to treat life-threatening cancers, today announced that Gail McIntyre, Ph.D., DABT ...
|
|
Monday, November 15, 2021 04:05 AM
First studio acquisition for Private Division brings wealth of development talent, creativity, and style of beloved OlliOlli creators to label NEW YORK, November 15, 2021--(BUSINESS WIRE)--Private ...
|
|
Monday, November 15, 2021 04:02 AM
HOUSTON, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing transformative, targeted therapeutics to treat ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/12/21 | 3.09 | 3.09 | 2.97 | 3.01 | 74,403 |
| 01/12/21 | 3.28 | 3.28 | 3.03 | 3.07 | 93,537 |
| 30/11/21 | 3.25 | 3.35 | 3.15 | 3.22 | 134,055 |
| 29/11/21 | 3.43 | 3.45 | 3.25 | 3.25 | 123,921 |
| 26/11/21 | 3.35 | 3.49 | 3.2808 | 3.39 | 103,077 |
| 24/11/21 | 3.48 | 3.548 | 3.45 | 3.50 | 79,774 |
| 23/11/21 | 3.51 | 3.56 | 3.48 | 3.49 | 84,565 |
| 22/11/21 | 3.62 | 3.6356 | 3.50 | 3.50 | 53,630 |
| 19/11/21 | 3.54 | 3.70 | 3.49 | 3.63 | 43,911 |
| 18/11/21 | 3.72 | 3.72 | 3.48 | 3.57 | 128,824 |
|
|
||||
|
|
||||
|
|